Literature DB >> 18752104

Negative symptoms in schizophrenia: a review.

J Mäkinen1, J Miettunen, M Isohanni, H Koponen.   

Abstract

Negative symptoms refer to the weakening or lack of normal thoughts, emotions or behaviour in schizophrenia patients. Their prevalence in first-episode psychosis is high, 50-90%, and 20-40% of schizophrenia patients have persisting negative symptoms. Severe negative symptoms during the early stages of treatment predict poor prognosis. The aim of the study was to review the current literature on the negative symptoms of schizophrenia. In June 2007, the following databases were searched: Web of Science, PubMed, PsycINFO, Medline (Ovid) and Scopus. The search included articles written in English and no time limit was determined. The studies were manually screened by one of the authors according to the title and abstract. About one in three schizophrenia patients suffer from significant negative symptoms. In these patients, negative symptoms constitute a key element of overall symptoms, weakening their ability to cope with everyday activities, affecting their quality of life and their ability to manage without significant outside help. About one in three schizophrenia patients suffer from significant negative symptoms. Attention should be focused on negative symptoms during the early phase of treatment, because they cause significant impairment to patients' quality of life. So far, no treatment appears to substantially improve negative symptoms narrowly defined. However, according to clinical experience, when treating negative symptoms, the best effect is achieved by optimizing the dose of medication and by complementing it with psychosocial therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18752104     DOI: 10.1080/08039480801959307

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  35 in total

1.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

2.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

Review 3.  Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Authors:  Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle
Journal:  J Neurosci Res       Date:  2016-11-08       Impact factor: 4.164

Review 4.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

5.  Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.

Authors:  Stefan Klingberg; Wolfgang Wölwer; Corinna Engel; Andreas Wittorf; Jutta Herrlich; Christoph Meisner; Gerhard Buchkremer; Georg Wiedemann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Negative symptoms and social cognition: identifying targets for psychological interventions.

Authors:  Tania M Lincoln; Stephanie Mehl; Marie-Luise Kesting; Winfried Rief
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

7.  Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes.

Authors:  Juliet Silberstein; Philip D Harvey
Journal:  Cogn Neuropsychiatry       Date:  2018-11-26       Impact factor: 1.871

8.  A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia.

Authors:  Shi-Fu Xiao; Hai-Bo Xue; Xia Li; Chao Chen; Guan-Jun Li; Cheng-Mei Yuan; Ming-Yuan Zhang
Journal:  Neurosci Bull       Date:  2011-08       Impact factor: 5.203

9.  Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophrenia.

Authors:  Jing Sui; Hao He; Godfrey D Pearlson; Tülay Adali; Kent A Kiehl; Qingbao Yu; Vince P Clark; Eduardo Castro; Tonya White; Bryon A Mueller; Beng C Ho; Nancy C Andreasen; Vince D Calhoun
Journal:  Neuroimage       Date:  2012-10-26       Impact factor: 6.556

10.  The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Joseph Ventura; Denise Gretchen-Doorly; Gerhard S Hellemann; Elisha R Agee; Laurie R Casaus; John S Luo; Kathleen F Villa; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-08-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.